OA09037A - Prevention and treatement of retroviral disease. - Google Patents

Prevention and treatement of retroviral disease.

Info

Publication number
OA09037A
OA09037A OA59525A OA59525A OA09037A OA 09037 A OA09037 A OA 09037A OA 59525 A OA59525 A OA 59525A OA 59525 A OA59525 A OA 59525A OA 09037 A OA09037 A OA 09037A
Authority
OA
OAPI
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
OA59525A
Other languages
English (en)
Inventor
Jonas Salk
Dennis J Carlo
Salk Jonas
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of OA09037A publication Critical patent/OA09037A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
OA59525A 1987-06-10 1989-02-10 Prevention and treatement of retroviral disease. OA09037A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31

Publications (1)

Publication Number Publication Date
OA09037A true OA09037A (en) 1991-03-31

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59525A OA09037A (en) 1987-06-10 1989-02-10 Prevention and treatement of retroviral disease.

Country Status (14)

Country Link
EP (3) EP0602761A1 (de)
JP (1) JPH0720880B2 (de)
AT (1) ATE132374T1 (de)
AU (1) AU612383B2 (de)
CA (1) CA1336407C (de)
DE (1) DE3854857T2 (de)
DK (1) DK56389D0 (de)
FI (1) FI95871C (de)
IL (1) IL86675A (de)
NO (1) NO175846C (de)
OA (1) OA09037A (de)
RU (1) RU2111010C1 (de)
UA (1) UA27716C2 (de)
WO (1) WO1988009670A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287226A1 (de) * 1987-03-23 1988-10-19 Hiver Limited Impfstoff
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (en) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Method of producing core structure of retro virus and particle produced thereby
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ES2141929T3 (es) * 1994-03-22 2000-04-01 Immune Response Corp Inc Produccion y aislamiento muy eficientes de particulas viricas.
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
EP0187041B1 (de) * 1984-12-24 1996-05-15 Genentech, Inc. Fusionen von AIDS-verwandten Polypeptiden
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
EP0249611A4 (de) * 1985-11-14 1988-04-26 Harvard College T-lymphotrophisches virus.
EP0250128A3 (de) * 1986-06-18 1988-06-08 American Registry of Pathology Von AIDS-Patienten isoliertes Virus
WO1988007058A1 (en) * 1987-03-16 1988-09-22 Biosolutions Pty. Ltd. Anti-paratopic antibody as an immunogen

Also Published As

Publication number Publication date
JPH02500440A (ja) 1990-02-15
DE3854857D1 (de) 1996-02-15
DK56389A (da) 1989-02-08
NO175846B (de) 1994-09-12
CA1336407C (en) 1995-07-25
FI890603A (fi) 1989-02-08
FI95871C (fi) 1996-04-10
ATE132374T1 (de) 1996-01-15
AU612383B2 (en) 1991-07-11
FI890603A0 (fi) 1989-02-08
JPH0720880B2 (ja) 1995-03-08
AU1962688A (en) 1989-01-04
UA27716C2 (uk) 2000-10-16
EP0602761A1 (de) 1994-06-22
EP0317622A1 (de) 1989-05-31
EP0317622A4 (de) 1990-05-14
DE3854857T2 (de) 1996-08-22
NO890565D0 (no) 1989-02-09
EP0685236A1 (de) 1995-12-06
FI95871B (fi) 1995-12-29
NO890565L (no) 1989-02-09
NO175846C (no) 1994-12-21
IL86675A (en) 1993-04-04
EP0317622B1 (de) 1996-01-03
WO1988009670A1 (en) 1988-12-15
RU2111010C1 (ru) 1998-05-20
DK56389D0 (da) 1989-02-08

Similar Documents

Publication Publication Date Title
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
DE69426077D1 (de) Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
ATE418562T1 (de) Ctl epitope des epstein-barr virus
ATE331026T1 (de) Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel
EP0232798A3 (de) Pseudorabies-Virus-Mutanten, diese enthaltende Vakzine, Verfahren zu deren Herstellung sowie Methoden für deren Anwendung
EP1375511A3 (de) Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus
OA09037A (en) Prevention and treatement of retroviral disease.
IL139360A0 (en) Viral chimeras comprised of caev and hiv-1 genetic elements
HK1021133A1 (en) Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
WO1991008771A3 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
CA2249736A1 (en) Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов